Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

LON/0K6R stock hub

LON/0K6R has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0K6Ris not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

11.2B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0K6R

In the news

Latest news · LON/0K6R

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E12.9

P25 12.9P50 16.9P75 23.5

Trailing P/E22.2

P25 15.9P50 22.9P75 35.8

ROE22.5

P25 -54.2P50 2.1P75 13.7

ROIC23.7

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0K6R market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

218

Groups with data

Currency

USD

Showing 218 of 218 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	2,000
Employees Change	400%
Employees Change Percent	28.57
Enterprise value	$10.6B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	US64125C1099
Last refreshed	2026-05-10
Market cap	$11.2B
Price	$154
Price currency	USD
Rev Per Employee	1,174,731.52x
Sector	Healthcare
Sic	2836
Symbol	lon/0K6R
Website	https://www.neurocrine.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.51%
EV Earnings	20.95x
EV/EBIT	18.1x
EV/EBITDA	16.27x
EV/FCF	16.85x
EV/Sales	4.66x
FCF yield	5.6%
Forward P/E	12.91x
P/B ratio	4.35x
P/E ratio	22.19x
P/S ratio	4.78x
PE Ratio10 Y	154.83x
PE Ratio3 Y	38.65x
PE Ratio5 Y	94.5x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	25.75%
EBITDA Margin	26.71%
FCF margin	26.8%
Gross margin	64.37%
Gross Profit	$1.5B
Gross Profit Growth	29.51%
Gross Profit Growth Q	68.05%
Gross Profit Growth3 Y	23.11%
Gross Profit Growth5 Y	21.81%
Net Income	$506.3M
Net Income Growth	118.64%
Net Income Growth Q	2,405.06%
Net Income Growth Quarters	4%
Net Income Growth Years	4%
Net Income Growth3 Y	118.61%
Net Income Growth5 Y	10.71%
Pretax Margin	30.22%
Profit Margin	21.55%
Profit Per Employee	$253,167
Profitable Years	8
ROA	11.62
Roa5y	8.57
ROCE	19.6
ROE	22.5
Roe5y	12.08
ROIC	23.74
Roic5y	20.75

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	27.33%
Cagr3y	16.76%
Cagr5y	11.43%
EPS Growth	119.9
EPS Growth Q	2,310.5
EPS Growth Quarters	4
EPS Growth Years	4
EPS Growth3 Y	115.8
EPS Growth5 Y	9.71
FCF Growth	68.9%
FCF Growth Q	152.68%
FCF Growth3 Y	51.88%
FCF Growth5 Y	25.58%
OCF Growth	62.99%
OCF Growth Q	125%
OCF Growth3 Y	50.24%
OCF Growth5 Y	25.24%
Revenue Growth	28.59x
Revenue Growth Q	42.25x
Revenue Growth Quarters	19x
Revenue Growth Years	9x
Revenue Growth3 Y	24.74x
Revenue Growth5 Y	24.3x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.72
Assets	$3.7B
Cash	$996.8M
Current Assets	$1.8B
Current Liabilities	$610.1M
Debt	$351M
Debt EBITDA	$0.52
Debt Equity	$0.14
Debt FCF	$0.56
Equity	$2.6B
Liabilities	$1.1B
Long Term Assets	$1.9B
Long Term Liabilities	$525M
Net Cash	$645.8M
Net Cash By Market Cap	$5.75
Net Cash Growth	89.32%
Net Debt EBITDA	$-1.03
Net Debt Equity	$-0.25
Net Debt FCF	$-1.03
Tangible Book Value	$2.6B
Tangible Book Value Per Share	$25.65
WACC	5.91

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.93
Inventory Turnover	17.89
Net Working Capital	$261.6M
Quick ratio	2.51
Working Capital	$1.2B
Working Capital Turnover	$1.73

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.68%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	27.31%
200-day SMA	137.5
3Y total return	59.19%
50-day SMA	131.5
50-day SMA vs 200-day SMA	50under200
5Y total return	71.77%
All Time High	161.1
All Time High Change	-4.27%
All Time High Date	2025-12-08
All Time Low	67.31
All Time Low Change	129.04%
All Time Low Date	2019-01-02
ATR	5.17
Beta	0.34
Ch YTD	8.63
High	154.2
High52	161.1
High52 Date	2025-12-08
High52ch	-4.27%
Low	147.6
Low52	116.2
Low52 Date	2025-05-12
Low52ch	32.67%
Ma50ch	17.2%
Price vs 200-day SMA	12.12%
RSI	77.28
RSI Monthly	60.03
RSI Weekly	63.3
Sharpe ratio	1.07x
Sortino ratio	1.85
Total Return	0.68%
Tr YTD	8.63
Tr1m	16.68%
Tr1w	18.02%
Tr3m	8.55%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$604.9M
Operating Income Growth	54.99
Operating Income Growth Q	684.8
Operating Income Growth3 Y	42.58
Operating Income Growth5 Y	21.63
Operating margin	25.75

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	99,259,897%
Shares Insiders	1.21%
Shares Institutions	99.48%
Shares Qo Q	-0.29%
Shares Yo Y	-0.68%
Short Ratio	4.68

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$461.2M
Average Volume	267.2x
Bv Per Share	25.65
CAPEX	$-24.5M
Ch1m	16.68
Ch1w	18.02
Ch1y	27.31
Ch3m	8.55
Ch3y	59.19
Ch5y	71.77
Ch6m	3.01
Change	3.5%
Change From Open	2.83
Close	149
Days Gap	0.66
Depreciation Amortization	21,858,717.2
Dollar Volume	32,838.2
Earnings Date	2026-05-05
EBIT	$604.9M
EBITDA	$627.5M
EPS	$4.92
F Score	6
FCF	$629.5M
FCF EV Yield	5.93x
Financing CF	-4,922,483
Fiscal Year End	December
Founded	1,992
Graham Number	74.40333
Graham Upside	-51.74
Income Tax	$203.6M
Investing CF	-594,332,964
Is Primary Listing	0
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Lynch Fair Value	$74.42
Lynch Upside	-51.73
Ma150	137.9
Ma150ch	11.83%
Ma20	133.3
Ma20ch	15.67%
Net CF	54,828,882
Open	149.9
P FCF Ratio	17.85
P OCF Ratio	17.18
Position In Range	100
Ppne	394,630,532
Price Date	2026-05-08
Price EBITDA	$17.9
Ptbv Ratio	4.35
Relative Volume	0.81x
Revenue	2,349,463,032x
SBC By Revenue	7.17x
Share Based Comp	168,348,902
Tax By Revenue	8.67x
Tax Rate	28.68%
Tr6m	3.01%
Volume	213
Z Score	6.99

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0K6R pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0K6R stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0K6R?

Insider, institutional, and short-interest positioning.

Institutional ownership

+99.5%

Share of float held by funds and institutions

Insider ownership

+1.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0K6R momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

77.3

Above 70: short-term overbought

Price vs 200-day MA

+12.1%

50/200-day relationship not available

Beta (5Y)

0.34

Less volatile than the market

Sharpe ratio

1.07

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0K6R

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0K6R stock rating?

lon/0K6R is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0K6R analysis?

The full report lives at /stocks/lon/0K6R/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0K6R?

The latest report frames lon/0K6R around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0K6R page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.